Analyst Price Targets — SIBN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 12:24 pm | — | Truist Financial | $24.00 | $15.62 | TheFly | SI-Bone price target raised to $24 from $23 at Truist |
| December 18, 2025 2:15 pm | — | Truist Financial | $23.00 | $19.62 | TheFly | SI-Bone price target raised to $23 from $21 at Truist |
| December 17, 2025 12:28 pm | William Plovanic | Canaccord Genuity | $27.00 | $19.42 | TheFly | SI-Bone price target raised to $27 from $26 at Canaccord |
| December 16, 2025 11:46 am | David Saxon | Needham | $27.00 | $19.16 | StreetInsider | SI-BONE Inc. (SIBN) PT Raised to $27 at Needham, Added To Conviction List |
| December 2, 2025 11:36 am | — | Morgan Stanley | $23.00 | $18.87 | TheFly | SI-Bone price target raised to $23 from $20 at Morgan Stanley |
| October 15, 2025 12:46 pm | Richard Newitter | Truist Financial | $20.00 | $15.27 | TheFly | SI-Bone price target lowered to $20 from $22 at Truist |
| August 11, 2025 11:10 am | Ross Osborn | Cantor Fitzgerald | $25.00 | $15.68 | StreetInsider | Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN) |
| August 6, 2024 7:40 am | Samuel Brodovsky | Truist Financial | $18.00 | $14.04 | TheFly | SI-Bone price target lowered to $18 from $20 at Truist |
| August 6, 2024 7:16 am | David Saxon | Needham | $19.00 | $14.36 | StreetInsider | SI-BONE Inc. (SIBN) PT Lowered to $19 at Needham |
| March 28, 2024 6:40 am | Matt O'Brien | Piper Sandler | $25.00 | $15.82 | TheFly | SI-Bone initiated with an Overweight at Piper Sandler |
Latest News for SIBN
SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.…
SiBone (NASDAQ: SIBN - Get Free Report)'s share price was down 6.8% during trading on Friday. The company traded as low as $12.82 and last traded at $12.7650. Approximately 417,589 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 607,897 shares. The stock had previously closed at $13.69.
JPMorgan Chase and Co. decreased its stake in SiBone (NASDAQ: SIBN) by 32.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 185,619 shares of the company's stock after selling 87,788 shares during the period. JPMorgan Chase and Co.
Shares of SiBone (NASDAQ: SIBN - Get Free Report) hit a new 52-week low during trading on Friday. The stock traded as low as $12.47 and last traded at $12.5850, with a volume of 33378 shares changing hands. The stock had previously closed at $12.84. Wall Street Analysts Forecast Growth Several equities research analysts have
Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SIBN.
U.S. House Trading
No House trades found for SIBN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.